Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button.
作者信息
Holstein Sarah A, Vose Julie M
机构信息
Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
出版信息
Clin Pharmacol Ther. 2020 Sep;108(3):422-424. doi: 10.1002/cpt.1920. Epub 2020 Jun 27.
Abstract
摘要
相似文献
1
Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button.COVID-19时代的肿瘤治疗：我们不能按下暂停键。
Clin Pharmacol Ther. 2020 Sep;108(3):422-424. doi: 10.1002/cpt.1920. Epub 2020 Jun 27.
2
Collateral damage of COVID-19 pandemic on oncology clinical trials.2019年冠状病毒病疫情对肿瘤学临床试验的附带损害。
Chin Clin Oncol. 2020 Dec;9(6):80. doi: 10.21037/cco-20-200. Epub 2020 Nov 18.
3
[Congress of the American Society of Clinical Oncology].[美国临床肿瘤学会大会]
J Chir (Paris). 2002 Oct;139(5):300-3.
4
Proposals for managing patients with thoracic malignancies during COVID-19 pandemic.COVID-19 大流行期间胸内恶性肿瘤患者的管理建议。
Respir Med Res. 2020 Nov;78:100769. doi: 10.1016/j.resmer.2020.100769. Epub 2020 May 24.
5
Dose-response relationship in clinical oncology.临床肿瘤学中的剂量-反应关系。
Cancer. 1984 Sep 15;54(6 Suppl):1204-7. doi: 10.1002/1097-0142(19840915)54:1+<1204::aid-cncr2820541318>3.0.co;2-z.
6
Do molecularly targeted agents in oncology have reduced attrition rates?肿瘤学中的分子靶向药物是否具有更低的淘汰率？
Nat Rev Drug Discov. 2009 Jan;8(1):15-6. doi: 10.1038/nrd2758. Epub 2008 Nov 14.
7
A Survey of Parents on the Effects of COVID-19 Pandemic on Children Receiving Antileukemic Therapy.一项关于新冠疫情对接受抗白血病治疗儿童影响的家长调查。
J Pediatr Hematol Oncol. 2021 Jul 1;43(5):e740-e741. doi: 10.1097/MPH.0000000000001969.
8
Challenges and recommendations for cancer care in the COVID-19 pandemic.2019年冠状病毒病大流行期间癌症护理面临的挑战与建议
Cancer Biol Med. 2020 Aug 15;17(3):515-518. doi: 10.20892/j.issn.2095-3941.2020.0300.
9
Cardio-oncology Training in the COVID-19 Era.心血管肿瘤学在 COVID-19 时代的培训。
Curr Treat Options Oncol. 2021 Jun 7;22(7):58. doi: 10.1007/s11864-021-00855-y.
10
Characterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.描述儿科肿瘤患者的 COVID-19 疾病特征：纽约-新泽西地区的经验。
Pediatr Blood Cancer. 2021 Mar;68(3):e28843. doi: 10.1002/pbc.28843. Epub 2020 Dec 18.
引用本文的文献
1
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.《COVID-19 大流行期间的癌症患者管理：ESMO 多学科专家共识》
Ann Oncol. 2020 Oct;31(10):1320-1335. doi: 10.1016/j.annonc.2020.07.010. Epub 2020 Jul 31.
本文引用的文献
1
Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.COVID-19 对肿瘤学临床试验开展的早期影响及长期变革机遇：美国临床肿瘤学会调查研究结果。
JCO Oncol Pract. 2020 Jul;16(7):417-421. doi: 10.1200/OP.20.00275. Epub 2020 May 12.
2
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System.纽约医院系统中 COVID-19 癌症患者的病死率。
Cancer Discov. 2020 Jul;10(7):935-941. doi: 10.1158/2159-8290.CD-20-0516. Epub 2020 May 1.
3
The many faces of the anti-COVID immune response.抗新冠病毒免疫反应的多面性。
J Exp Med. 2020 Jun 1;217(6). doi: 10.1084/jem.20200678.
4
Management of patients with multiple myeloma during the COVID-19 pandemic.2019冠状病毒病大流行期间多发性骨髓瘤患者的管理
Lancet Haematol. 2020 Jun;7(6):e435-e437. doi: 10.1016/S2352-3026(20)30124-1. Epub 2020 Apr 27.
5
Effect of the COVID-19 pandemic on cancer treatment and research.2019冠状病毒病大流行对癌症治疗及研究的影响。
Lancet Haematol. 2020 Jun;7(6):e432-e435. doi: 10.1016/S2352-3026(20)30123-X. Epub 2020 Apr 24.
6
Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic.适应大流行——在 SARS-CoV-2 大流行期间开展肿瘤学试验。
Clin Cancer Res. 2020 Jul 1;26(13):3100-3103. doi: 10.1158/1078-0432.CCR-20-1364. Epub 2020 Apr 20.
7
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.SARS-CoV-2 在武汉一家三级医院癌症患者中的传播。
JAMA Oncol. 2020 Jul 1;6(7):1108-1110. doi: 10.1001/jamaoncol.2020.0980.
8
The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.临床试验参与在癌症研究中的作用：障碍、证据与策略
Am Soc Clin Oncol Educ Book. 2016;35:185-98. doi: 10.1200/EDBK_156686.
9
Time to activate lung cancer clinical trials and patient enrollment: a representative comparison study between two academic centers across the atlantic.启动肺癌临床试验和患者招募的时机：大西洋两岸两个学术中心的代表性对比研究。
J Clin Oncol. 2010 Aug 20;28(24):3803-7. doi: 10.1200/JCO.2010.28.1824. Epub 2010 Jul 19.
10
Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.肿瘤临床试验的无形障碍：开展肿瘤临床试验时结构、基础设施及程序方面的障碍所产生的影响
J Clin Oncol. 2006 Oct 1;24(28):4545-52. doi: 10.1200/JCO.2005.05.0104.
Zotero 插件